| abstract |
The invention relates to the use of neurokinin -1 receptor antagonists as testosterone replacement therapy. In a further aspect the invention relates to the use of neurokinin-1 receptor antagonists for the preparation of medicaments for treating conditions associated with low testosterone levels, in patients having deficient testosterone levels. In another aspect the invention relates to the use of neurokinin -1 receptor antagonists for the preparation of medicaments for treating hypogonadism in men. |